MELA Sciences, Inc. (MELA) Pioneering Earlier Detection of Melanoma Is Featured in Flaherty Financial News Newsletter #41

MELA Sciences, Inc. (MELA) Pioneering Earlier Detection of Melanoma Is Featured 
in Flaherty Financial News Newsletter #41 
WEST HARRISON, NY -- (Marketwired) -- 03/11/14 --  Fine tuning the
crusade by MELA Sciences, Inc. (NASDAQ: MELA) to identify deadly
melanoma earlier is featured in the March 10, 2014 issue of Flaherty
Financial News Newsletter. It follows up two previous articles
written four years ago.  
One American an hour is dying from melanoma for which in advanced
cases there is no cure. Partly due to the widespread use of tanning
beds, more young women are dying of melanoma than any other cancer.
Modern imaging technology being pioneered by MELA to replace the less
reliable naked eyeball skin lesion inspections performed today can
make a difference. Many of the agonizing 8,760 yearly annual deaths
from melanoma can be prevented by earlier detection.  
New President and CEO Rose A. Crane covered the turnaround changes in
MELA Sciences, Inc.'s business model to bring imaging technology to
dermatologists, the last large healthcare holdout group. MELA imaging
will be a revolution. As opposed to just looking with the naked eye,
doctors will be able to understand more of what they are seeing.  
The complete article containing our MELA CEO profile presentation
snapshot can be found archived on our Flaherty Financial News website
at http://www.flahertyfinancialnews.com/.   
Direct Server Link To The Report:  
http://archive.constantcontact.com/fs141/1101855435216/archive/1116768935039.htm
l 
Server Link to The Report - With The Modern Social Share Buttons:  
http://campaign.r20.constantcontact.com/render?ca=f75f159d-6d7f-4504-93c9-f11a3205e909&c=ba013f80-1d50-11e3-bf73-d4ae52754007&ch=ba97b320-1d50-11e3-bf9e-d4ae52754007 
About Flaherty Financial News Inc. 
 Flaherty Financial News Inc.
("FFN") is the publisher of totally-electronic coverage of
interesting public companies. FFN was launched in February 2007 by
the "legendary financial editor" Bob Flaherty, Editor and Chairman of
Flaherty Financial News Inc., and his son Brian, President and
Publisher. While previously serving as Chairman and Editor of
Equities Magazine for twenty-five years and also Editor-in-Chief of
Equities Special Situations, Bob had one of the most consistent and
highest ranked long-run performance records measured by Hulbert
Financial Digest. He is also an award-winning retired Senior Editor
of Forbes Magazine, where he wrote 33 cover stories, two shy of the
all-time Forbes record. He was also Chairman of The Over-The-Counter
Securities Fund. Bob Flaherty is a Magna Cum Laude graduate of
Harvard College in economics and also has an MBA with a Distinction
in Finance from Harvard Business School. A former president of the
New York Financial Writers' Association, Bob is a co-founder of their
annual student scholarship program and their annual award for
significant long-term achievement in financial journalism.  
Forward-Looking Statements: 
 This news release contains
"forward-looking statements" (as defined in the Private Securities
Litigation Reform Act of l995) regarding the snapshot of the MELA
Sciences, Inc. CEO company profile presentation and its future
business plans. These statements involve known and unknown risks and
uncertainties. Such risks and uncertainties may cause actual results
and future achievements of all of the companies to be materially
different than those implied by these forward-looking statements.
Flaherty Financial News Inc. and MELA Sciences, Inc. have and
undertake no obligation to provide public updates and revisions to
these forward-looking statements to reflect any changes in their
expectations of future events.  
Contact: 
Flaherty Financial News Inc. 
Brian D. Flaherty
President and Publisher
Tel: (914) 539-0688
http://www.flahertyfinancialnews.com/ 
 
 
Press spacebar to pause and continue. Press esc to stop.